Lungs News and Research

RSS

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

For World Tuberculosis Day 2022, News Medical spoke to Dr. Michael Lauzardo, director of the Southeastern National TB Center, to raise awareness of this infectious disease.

24 Mar 2022

Researchers aim to study the underlying pathophysiology of diastolic heart failure

Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF). Also known as diastolic heart failure, HFpEF occurs when the heart's lower left chamber loses its ability to relax and fill up with enough blood in between in each heartbeat.

23 Mar 2022

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Scientists have discovered a new family of helpful proteins in the lung, with the finding potentially paving the way for a new course of treatment for patients with respiratory failure.

23 Mar 2022

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Researchers investigated how monoclonal antibodies, S309 and AZD7442, reduced lung infection in mice infected with the SARS-CoV-2 new variant of concern Omicron's BA.1, BA.1.1, and BA.2 sublineages.

23 Mar 2022

New magnetic tentacle robot can reach the smallest bronchial tubes in the lung

Engineers and scientists have developed proof of concept for a robot that can reach some of the smallest bronchial tubes in the lungs - to take tissue samples or deliver cancer therapy.

23 Mar 2022

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

It is becoming increasingly clear that individuals recovering from acute coronavirus disease (COVID-19) may develop post-acute sequelae (Post-Acute Coronavirus Syndrome, PACS).

23 Mar 2022

New model suggests long-range transmission of SARS-CoV-2

A new study describes the long-range transmission of SARS-CoV-2 through aerosolized particles as a possibility.

22 Mar 2022

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that’s given to half of all hospitalized patients with the disease.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Antimalarial drugs are also effective at treating a pulmonary disease, study finds

A research team at Colorado State University has discovered that drugs used to treat malaria are also effective at treating a pulmonary disease similar to tuberculosis.

21 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people -; but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

IU researchers exploring new ways to treat seasonal or intermittent asthma

Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma.

21 Mar 2022

SARS-CoV-2 infection found to reduce fetal lung volume as assessed by MRI

Researchers evaluated the impact of SARS-CoV-2 infection in gestational women on fetal pulmonary development using magnetic resonance imaging.

21 Mar 2022

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Researchers assessed the impact of recombinant accessory protein-deficient severe acute respiratory syndrome coronavirus 2 immunization against SARS-CoV-2 transmission and disease severity.

18 Mar 2022

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Researchers assessed the role of hypoxia-inducible factors in SARS-CoV-2 infection, respiratory symptoms, and epithelial damage.

18 Mar 2022

Study shows small airways disease with the presence of air trapping is a long-lasting sequelae of SARS-CoV-2 infection

Researchers investigated whether small airway diseases are present following acute SARS-CoV-2 infection.

18 Mar 2022

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Researchers tested the effectiveness of the BCG vaccine in SARS-CoV-2-infected Syrian hamsters.

18 Mar 2022

Excessive neuropeptide secretion in the lungs can lead to fluid buildup and poor oxygenation

COVID-19 has put a spotlight on the pulmonary and nervous systems, but there is still much to learn about how they interact. Researchers at University of California San Diego School of Medicine recently explored this relationship in the context of a childhood lung disease, but their findings may also apply to COVID-19 symptoms.

17 Mar 2022

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Researchers assessed the efficacy of vesicular stomatitis virus-based coronavirus disease 2019 vaccines in Syrian golden hamsters.

17 Mar 2022

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

Researchers studied the immune responses in Syrian hamsters re-infected with SARS-CoV-2 Delta and B.1 variants three months after the primary infection.

17 Mar 2022

Lungs News and Research

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

Researchers aim to study the underlying pathophysiology of diastolic heart failure

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

New magnetic tentacle robot can reach the smallest bronchial tubes in the lung

Detection of immune and clotting dysfunction in plasma and saliva after SARS-CoV-2 infection

New model suggests long-range transmission of SARS-CoV-2

Oral version of remdesivir could extend its reach and benefits to COVID-19 patients

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Antimalarial drugs are also effective at treating a pulmonary disease, study finds

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

IU researchers exploring new ways to treat seasonal or intermittent asthma

SARS-CoV-2 infection found to reduce fetal lung volume as assessed by MRI

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Study shows small airways disease with the presence of air trapping is a long-lasting sequelae of SARS-CoV-2 infection

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Excessive neuropeptide secretion in the lungs can lead to fluid buildup and poor oxygenation

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Study reports reduced disease severity in Syrian hamsters during re-infection with SARS-CoV-2 Delta variant

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News